| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |